An ErbB3 antibody, MM-121, is active in cancers with ligand dependent activation

ErbB3 is a critical activator of PI3K signaling in EGFR (ErbB1), ErbB2 (HER2), and MET addicted cancers, and reactivation of ErbB3 is a prominent method for cancers to become resistant to ErbB inhibitors. In this study, we evaluated the in vivo efficacy of a therapeutic anti-ErbB3 antibody, MM-121....

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Schoeberl, Birgit, Faber, Anthony C., Li, Danan, Liang, Mei-Chih, Crosby, Katherine, Onsum, Matthew, Burenkova, Olga, Pace, Emily, Walton, Zandra, Nie, Lin, Fulgham, Aaron, Song, Youngchul, Nielsen, Ulrik B., Engelman, Jeffrey A., Wong, Kwok-Kin
Format: Artigo
Langue:Inglês
Publié: 2010
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2840205/
https://ncbi.nlm.nih.gov/pubmed/20215504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-09-3145
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires